Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Estrella Lasry

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
BMC Infectious Diseases|June 13, 2015
A multi-center, open-label trial to compare the efficacy and pharmacokinetics of Artemether-Lumefantrine in children with severe acute malnutrition versus children without severe acute malnutrition: study protocol for the MAL-NUT studyLise Denoeud-Ndam, Alassane Dicko, Elisabeth Baudin, et al.
Malaria Journal|November 11, 2023
Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South SudanIrene Molina-de la Fuente, María José Sagrado Benito, Estrella Lasry, et al.
Plos One|September 24, 2016
Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in MaliHamma Maiga, Estrella Lasry, Modibo Diarra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2022
AmBisome Monotherapy and Combination AmBisome-Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 TrialSakib Burza, Raman Mahajan, Shahwar Kazmi, et al.
The Journal of Infectious Diseases|July 26, 2015
Multidistrict Outbreak of Marburg Virus Disease-Uganda, 2012Barbara Knust, Ilana J Schafer, Joseph Wamala, et al.
BMC Medicine|October 26, 2016
Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and NigerLise Denoeud-Ndam, Alassane Dicko, Elisabeth Baudin, et al.
BMC Medicine|February 27, 2020
The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient dataMichael T Bretscher, Prabin Dahal, Jamie Griffin, et al.
BMJ Open|January 26, 2021
Prediction of disease severity in young children presenting with acute febrile illness in resource-limited settings: a protocol for a prospective observational studyArjun Chandna, Endashaw M Aderie, Riris Ahmad, et al.
BMC Medicine|January 20, 2018
Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan AfricaW Robert Taylor, Htee Khu Naw, Kathryn Maitland, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
BMC Infectious Diseases|June 13, 2015
A multi-center, open-label trial to compare the efficacy and pharmacokinetics of Artemether-Lumefantrine in children with severe acute malnutrition versus children without severe acute malnutrition: study protocol for the MAL-NUT studyLise Denoeud-Ndam, Alassane Dicko, Elisabeth Baudin, et al.
Malaria Journal|November 11, 2023
Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South SudanIrene Molina-de la Fuente, María José Sagrado Benito, Estrella Lasry, et al.
Plos One|September 24, 2016
Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in MaliHamma Maiga, Estrella Lasry, Modibo Diarra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2022
AmBisome Monotherapy and Combination AmBisome-Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 TrialSakib Burza, Raman Mahajan, Shahwar Kazmi, et al.
The Journal of Infectious Diseases|July 26, 2015
Multidistrict Outbreak of Marburg Virus Disease-Uganda, 2012Barbara Knust, Ilana J Schafer, Joseph Wamala, et al.
BMC Medicine|October 26, 2016
Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and NigerLise Denoeud-Ndam, Alassane Dicko, Elisabeth Baudin, et al.
BMC Medicine|February 27, 2020
The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient dataMichael T Bretscher, Prabin Dahal, Jamie Griffin, et al.
BMJ Open|January 26, 2021
Prediction of disease severity in young children presenting with acute febrile illness in resource-limited settings: a protocol for a prospective observational studyArjun Chandna, Endashaw M Aderie, Riris Ahmad, et al.
BMC Medicine|January 20, 2018
Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan AfricaW Robert Taylor, Htee Khu Naw, Kathryn Maitland, et al.
Pageof 2